Atacicept in Multiple Glomerular Diseases

Recruiting now · Phase 2

Conditions studied: pMN, IgAN, Nephrotic Syndrome, MCD, FSGS

In brief

A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.

Key facts

Study ID
NCT06983028
Run by
Vera Therapeutics, Inc.
People needed
250
Starts
2025-07-07
Expected to finish
2027-11-01
Last updated by the study team
2026-06-26

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.